For the Inventor, By the Inventor

Enter assignee name

N.v. Innogenetics S.a.

USPTO Granted Patents = 43

% Expired Patents = 18.6

Forward Citations = 528

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Rudi Rossau (9 out of 35 patents)

Geert Maertens (9 out of 42 patents)

Hugo Van Heuverswyn (9 out of 27 patents)

4. Marc Mercken (7 out of 24 patents)

5. Marc Vandermeeren (7 out of 16 patents)

6. Lieven Jozef Stuyver (7 out of 30 patents)

7. Eugeen Vanmechelen (7 out of 17 patents)

8. Jean Content (7 out of 8 patents)

9. Lucas De Wit (6 out of 6 patents)

10. Jacqueline De Bruyn (6 out of 6 patents)

11. Robert De Leys (6 out of 12 patents)

12. Jean-Paul Van Vooren (4 out of 4 patents)

13. Andre Van De Voorde (4 out of 7 patents)

14. Eva-Maria Mandelkow (3 out of 6 patents)

15. Hans Van Bossuyt (2 out of 3 patents)

Core Competencies:

Hepatitis C

Microtubule-Associated Protein Tau

Monoclonal Antibodies

Immunodiagnostic Assays

Polypeptides

Nucleic Acids

Hybridization Probes

Wound Healing

Mycobacterium

Peptides

Diagnostic Agents

Vaccine Development

43 patents: Sort by Forward Citations

1. 8163873 - Isolated microtubule-associated protein tau peptides and kit (2012-04-24),

2. 7855052 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2010-12-21),

3. 7279170 - [object Object] (2007-10-09),

4. 7255997 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2007-08-14),

5. 7195765 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2007-03-27),

6. 7122306 - Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents (2006-10-17),

7. 7083797 - [object Object] (2006-08-01),

8. 6900293 - Monoclonal antibodies directed against the microtubule-associated protein tau (2005-05-31),

9. 6855318 - Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes (2005-02-15),

10. 6709828 - PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM (2004-03-23),

11. 6667387 - HCV core peptides (2003-12-23),

12. 6656689 - Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms (2003-12-02),

13. 6649735 - PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM (2003-11-18),

14. 6638511 - Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis (2003-10-28),

15. 6585969 - Non-viable keratinocyte cell composition or lysate for promoting wound healing (2003-07-01),

Company Overview

N.v. Innogenetics S.a., headquartered in Ghent, Belgium, is a biotechnology company focused on the development of innovative diagnostic solutions and therapeutic products. The organization specializes in areas such as Hepatitis C Virus research, monoclonal antibodies, and peptide vaccines. Additionally, Innogenetics is engaged in the advancement of nucleic acids, hybridization probes, and immunodiagnostic assays, contributing significantly to the fields of infectious diseases and neurodegenerative disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

43 Patents

#6 in Ghent

#92 in Belgium

#16,040 in the World

N.v. Innogenetics S.a.

Forward Citations = 528

48 inventors:

Rudi Rossau (9 out of 35 patents)

Geert Maertens (9 out of 42 patents)

Hugo Van Heuverswyn (9 out of 27 patents)

4. Marc Mercken (7 out of 24 patents)

5. Marc Vandermeeren (7 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: N.v. Innogenetics S.a.. Retrieved from https://idiyas.com/company/n-v-innogenetics-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…